These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 16716307)
1. In vitro inhibition of transthyretin aggregate-induced cytotoxicity by full and peptide derived forms of the soluble receptor for advanced glycation end products (RAGE). Monteiro FA; Cardoso I; Sousa MM; Saraiva MJ FEBS Lett; 2006 Jun; 580(14):3451-6. PubMed ID: 16716307 [TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end products (AGE) and the receptor for AGE are present in gastrointestinal tract of familial amyloidotic polyneuropathy patients but do not induce NF-kappaB activation. Matsunaga N; Anan I; Forsgren S; Nagai R; Rosenberg P; Horiuchi S; Ando Y; Suhr OB Acta Neuropathol; 2002 Nov; 104(5):441-7. PubMed ID: 12410391 [TBL] [Abstract][Full Text] [Related]
4. Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation. Sousa MM; Yan SD; Stern D; Saraiva MJ Lab Invest; 2000 Jul; 80(7):1101-10. PubMed ID: 10908156 [TBL] [Abstract][Full Text] [Related]
5. V domain of RAGE interacts with AGEs on prostate carcinoma cells. Allmen EU; Koch M; Fritz G; Legler DF Prostate; 2008 May; 68(7):748-58. PubMed ID: 18302220 [TBL] [Abstract][Full Text] [Related]
6. Association of advanced glycation end products with A549 cells, a human pulmonary epithelial cell line, is mediated by a receptor distinct from the scavenger receptor family and RAGE. Nakano N; Fukuhara-Takaki K; Jono T; Nakajou K; Eto N; Horiuchi S; Takeya M; Nagai R J Biochem; 2006 May; 139(5):821-9. PubMed ID: 16751589 [TBL] [Abstract][Full Text] [Related]
7. Transthyretin is not expressed by dorsal root ganglia cells. Sousa MM; Saraiva MJ Exp Neurol; 2008 Dec; 214(2):362-5. PubMed ID: 18835560 [TBL] [Abstract][Full Text] [Related]
8. Receptor for advanced glycation end products (RAGE) mediates neuronal differentiation and neurite outgrowth. Wang L; Li S; Jungalwala FB J Neurosci Res; 2008 May; 86(6):1254-66. PubMed ID: 18058943 [TBL] [Abstract][Full Text] [Related]
9. Amyloid beta interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier. Li M; Shang DS; Zhao WD; Tian L; Li B; Fang WG; Zhu L; Man SM; Chen YH J Immunol; 2009 May; 182(9):5778-88. PubMed ID: 19380826 [TBL] [Abstract][Full Text] [Related]
10. Clusterin regulates transthyretin amyloidosis. Lee KW; Lee DH; Son H; Kim YS; Park JY; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi WS Biochem Biophys Res Commun; 2009 Oct; 388(2):256-60. PubMed ID: 19664600 [TBL] [Abstract][Full Text] [Related]
17. Soluble receptor for advanced glycation end products triggers a proinflammatory cytokine cascade via beta2 integrin Mac-1. Pullerits R; Brisslert M; Jonsson IM; Tarkowski A Arthritis Rheum; 2006 Dec; 54(12):3898-907. PubMed ID: 17133598 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of GSPE on RAGE expression induced by advanced glycation end products in endothelial cells. Zhang FL; Gao HQ; Shen L J Cardiovasc Pharmacol; 2007 Oct; 50(4):434-40. PubMed ID: 18049312 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products. Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488 [TBL] [Abstract][Full Text] [Related]
20. Formation of cytotoxic transthyretin is not dependent on inter-molecular disulphide bridges commonly found within the amyloid form. Lindhagen-Persson M; Vestling M; Reixach N; Olofsson A Amyloid; 2008 Dec; 15(4):240-5. PubMed ID: 19065295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]